CMR Surgical (CMR) – the global surgical robotics business – and Kebomed – one of Europe’s leading distributors of specialist medical devices – announces an agreement to bring the next-generation Surgical Robotic System, Versius, to Denmark, Norway, and Finland.
CMR’s system, Versius, is a small and modular surgical robot performing complex surgical cases. With its small footprint and lightweight design, Versius can be easily moved between departments so hospitals can maximise its utilisation, which can be critical for many centres adopting new technologies.
Henrik Schjødt, CEO and Head of the Board Kebomed Nordics, comments: “The Nordic countries are global leaders in the responsible introduction of healthcare technology, with a high bar for quality and cost-effectiveness. We are proud to partner with CMR to add Versius to our extensive portfolio and believe the introduction of Versius will offer all surgeons and hospitals the opportunity to transform how surgery is performed.”
Surgical robots have become well-established for their use in prostate cancer surgery; however, they are now increasingly being adopted for a broader range of surgical specialties including benign and complex gynaecology, colorectal and general surgery. Through using Versius as part of a multi-specialty robotics programme and converting more cases to minimal access procedures, hospitals have been found to save up to 450 bed days annually.[i]
Susanne Lehnberg Commercial Manager, for CMR Surgical, adds: “This is an exciting step for CMR as we continue to make robotic assisted surgery more widely accessible to patients around the world. We look forward to partnering with hospitals, surgeons and surgical teams across Denmark, Norway, and Finland to bring our highly versatile and digital solution to the operating room.”
This announcement follows the recent news that the first Versius system has been installed in Sweden, at NU-hospital group, a part of Västra Götalandregionen, in a first for the Nordic region. There are now over 160 Versius installations globally, with over 20,000 cases performed.